Description
What is Keytruda (Pembrolizumab) ?
KEYTRUDA (pembrolizumab) injection, for intravenous use. Initial U.S. Approval: 2014.
Keytruda is classified as a monoclonal antibody. Monoclonal antibodies are a relatively new type of “targeted” cancer therapy. Antibodies are an integral part of the body’s immune system. Normally, the body creates antibodies in response to an antigen (such as a protein in a germ) that has entered the body. The antibodies attach to the antigen in order to mark it for destruction by the immune system.
Pembrolizumab is a cancer medicine that interferes with the growth and spread of cancer cells in the body. It is used to treat advanced skin cancer (melanoma) that has spread to other parts of the body. It is also used to treat a certain type of non-small cell lung cancer, if your tumor has a specific genetic marker for which your doctor will test. Keytruda Pembrolizumab is also used to treat head and neck cancer that has spread to other parts of the body, or has come back after prior treatment. Pembrolizumab is also used to treat Hodgkin lymphoma in adults and children.
How to order approved “Keytruda (Pembrolizumab) for Injection” Medicine?
Brand Name “KEYTRUDA (pembrolizumab) injection” medication can be imported and made available on “Named Patient Program (NPP)” treatment in Philippines, Vietnam, Ireland and India. Please contact at +91 9910645395 (Mr. Rakesh) or make an enquiry at info@cancermedicinesnetwork to find the cost price to buy “KEYTRUDA (pembrolizumab) injection” online and have it delivered where you live. We take guarantee of quality and delivery as per the buyer’s requirements.